CJC-1295 With DAC vs Without DAC: What Tony Huge Actually Uses
Cognitive Enhancement1 min read
Summary
- CJC-1295 without DAC (Mod GRF 1-29): 30-min half-life, pulsatile GH, multiple daily injections, optimal for most goals
- CJC-1295 with DAC: 6-8 day half-life, continuous GH bleed, once/twice weekly, receptor downregulation risk
- Primary mechanism: GHRH receptor agonism → GH release from pituitary
- Tony’s position: Mod GRF 1-29 + ipamorelin for pulsatile physiology is superior
- DAC has a place: compliance situations, older individuals with blunted GH pulses
Mod GRF 1-29 (CJC Without DAC)
- Half-life: 30 minutes
- GH pattern: Sharp physiological pulse matching natural GH rhythm
- Dosing: 2-3x daily injections required
- GHRP synergy: Excellent, available at the exact moment ipamorelin triggers the pulse
CJC-1295 With DAC
- Half-life: 6-8 days
- GH pattern: Continuous “GH bleed”, non-pulsatile elevation
- Dosing: Once or twice weekly
- Receptor risk: Chronic non-pulsatile stimulation → GHRH receptor downregulation
The tony huge laws of biochemistry physics, Law 4: Self-Regulating Systems
This is Law 4 of the tony huge Laws of Biochemistry Physics in action: the body fights to maintain homeostasis. Your GHRH receptor system evolved for pulsatile stimulation, peaks and troughs. Constant stimulation from CJC with DAC triggers receptor downregulation, gradually diminishing the response. Mod GRF 1-29 works WITH the pulsatile design of your GH axis rather than fighting against it. The self-regulating system stays sensitive and responsive long-term.
Head-to-Head Comparison
| Factor | Mod GRF 1-29 | CJC-1295 with DAC |
|---|---|---|
| GH Pattern | Pulsatile (physiological) | Continuous (non-physiological) |
| Receptor Sensitivity | Preserved long-term | Downregulation risk |
| GHRP Synergy | Excellent | Reduced (timing mismatch) |
| Convenience | Multiple daily injections | 1-2x weekly |
| IGF-1 Response | Higher peaks | Steady but lower peaks |
Recommended Protocol
- Mod GRF 1-29: 100-200 mcg per injection, combined with ipamorelin 100-300 mcg
- Same syringe, 2-3x daily: fasted morning, and before sleep
- Fasted window: 30-60 min before and after, insulin blunts GH release
- Monitoring: IGF-1 at 4-6 weeks (expect 30-50% increase), fasting glucose quarterly
References
- Jetté L et al. “hGH-releasing peptide 2 stimulates the gh/IGF-1 axis.” Endocrinology, 2005.
- Ionescu M, Frohman LA. “Pulsatile secretion of growth hormone.” Endocr Rev, 2006.
See the complete GH optimization guide at Enhanced Athlete Protocol Peptides and Bloodwork Monitoring.
Education and personal experience only, not medical advice. 18+. Talk to a licensed doctor before you change anything about your health.
Read nextThe Complete Vilon Stack Protocol